In contrast, in patients with NSCLC and COPD receiving preoperative neoadjuvant immunotherapy, the MPR subgroup had a higher number of MAIT cells, higher levels of GZMB and IFNγ‐R, and lower levels of PD1 IL‐17A, than the NPR subgroup (Figure 3E). Here, IFNGR1 is linked to non-small cell lung carcinoma.